风险分层乳腺癌查 - 一个非盲目的随机试验的协议
Line Hjøllund Pedersen1,2, Janne Bigaard1, Pia Rørbæk Kamstrup3,4
1Prevention and Information, Danish Cancer Society.
Danish medical journal
|October 24, 2025
概括
这项研究评估了风险分层的乳腺癌查,使用多基因分数来个性化乳房镜间隔. 结果将指导未来的大规模试验,以获得更安全,更有效的查策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学是一种遗传学.
- 公共卫生 公共卫生
背景情况:
- 乳腺癌是女性癌症死亡的主要原因之一.
- 目前为50-69岁的女性进行两年一次的乳房扫描查,可以降低死亡率.
- 风险分层查可以改善早期检测,并减少低风险个体不必要的程序.
研究的目的:
- 研究多因素风险分层乳腺癌查的可行性,可接受性,成本效益和安全性.
- 评估基于个体风险的个性化查间隔的影响,包括多基因分数.
主要方法:
- 一项随机对照试验,涉及至少962名年龄在50-67岁的女性.
- 参与者被随机分配到标准查或风险分层间隔.
- 在线数据收集和跟踪使用共同设计的工具;主要结果是低风险女性的延迟乳房造影.
主要成果:
- 主要结局是低风险女性的比例延迟了800天的乳房镜检查.
- 二次结果包括生活质量,焦虑和担心乳腺癌.
- 将进行健康经济分析.
结论:
- 预计该研究的结果将为更大的风险分层查试验的设计提供信息.
- 这项研究旨在优化乳腺癌查协议.
更多相关视频
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
810
06:42Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
Published on: September 2, 2025
401
相关概念视频
Randomized Experiments
8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.8K
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404
Blind Procedures
12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
Hazard Ratio
559
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
559
